| 2026-03-16 | Class II | Meclizine Hydrochloride | Ongoing |
| 2026-01-14 | Class II | Oxycodone Hydrochloride | Ongoing |
| 2025-10-16 | Class II | Prazosin Hydrochloride | Ongoing |
| 2025-10-16 | Class II | Prazosin Hydrochloride | Ongoing |
| 2025-10-16 | Class II | Prazosin Hydrochloride | Ongoing |
| 2025-10-09 | Class II | Sucralfate | Ongoing |
| 2025-09-15 | Class II | Carbamazepine | Ongoing |
| 2025-08-27 | Class II | Chlorpromazine Hydrochloride | Ongoing |
| 2025-08-27 | Class II | Chlorpromazine Hydrochloride | Ongoing |
| 2025-08-27 | Class II | Chlorpromazine Hydrochloride | Ongoing |
| 2025-08-27 | Class II | Chlorpromazine Hydrochloride | Ongoing |
| 2025-07-29 | Class II | Sucralfate | Ongoing |
| 2025-05-15 | Class II | Indomethacin | Ongoing |
| 2025-04-02 | Class II | Haloperidol Decanoate | Ongoing |
| 2025-04-02 | Class II | Haloperidol Decanoate | Ongoing |
| 2025-04-02 | Class II | Haloperidol Decanoate | Ongoing |
| 2025-03-24 | Class II | Voriconazole | Terminated |
| 2025-01-07 | Class II | Clobazam | Ongoing |
| 2024-12-17 | Class II | glipiZIDE, Extended-Release Tablets, 2.5 mg, 30-count (3x10 blister cards) carton, Rx Only | Completed |
| 2024-12-13 | Class II | Clobazam | Ongoing |
| 2024-12-06 | Class II | Duloxetine Delayed-Release Capsules, USP, 30 mg, Rx only, 90 count bottles, Manufactured b | Ongoing |
| 2024-12-06 | Class II | Duloxetine Delayed-Release Capsules USP, 30 mg, Rx only, 30 count bottles, Manufactured by | Ongoing |
| 2024-12-06 | Class II | Duloxetine Delayed-Release Capsules, USP, 60 mg, Rx only, 1,000 count bottles, Manufacture | Ongoing |
| 2024-12-06 | Class II | Duloxetine Delayed-Release Capsules USP, 60 mg, Rx only, 30 count bottles, Manufactured by | Ongoing |
| 2024-11-14 | Class II | Duloxetine Delayed-Release Capsules, USP, 60 mg, Rx only, 1,000 count bottle, Manufactured | Ongoing |
| 2024-11-14 | Class II | Duloxetine Delayed-Release Capsules, USP, 20 mg, Rx only, 60 count bottles, Manufactured b | Ongoing |
| 2024-11-14 | Class II | Duloxetine Delayed-Release Capsules, USP, 30 mg, Rx only, a) 30 count (NDC 68001-414-04) a | Ongoing |
| 2024-06-25 | Class I | Potassium Chloride | Ongoing |
| 2024-06-24 | Class II | Bupropion Hydrochloride | Ongoing |
| 2024-02-01 | Class III | HydrALAZINE Hydrochloride Tablets, USP, 10 mg, 100-count (10 x 10) per unit dose carton, R | Ongoing |
| 2024-01-25 | Class II | Febuxostat | Terminated |
| 2024-01-11 | Class II | Rifampin | Terminated |
| 2023-12-26 | Class III | Benzonatate | Ongoing |
| 2023-09-01 | Class III | HydrALAZINE Hydrochloride Tablets, USP, 10 mg, 100 Tablets (10 x 10) per carton, Rx Only, | Terminated |
| 2023-06-23 | Class II | Tizanidine | Terminated |
| 2023-03-17 | Class II | Glimepiride Tablets, USP, 4 mg, RX, Packaged as a) 100-count bottle, NDC# 68001-179-00; b) | Terminated |
| 2023-03-17 | Class II | Glimepiride Tablets, USP, 1 mg, RX, Packaged as a)100-count bottle, NDC# 68001-177-00; b) | Terminated |
| 2023-03-17 | Class II | Glimepiride Tablets, USP, 2 mg, RX, Packaged as a ) 100-count bottle, NDC# 68001-178-00; | Terminated |
| 2023-03-16 | Class II | Verapamil Hydrochloride Extended-Release Tablets, USP, 180 mg, 100 Tablets (10 x 10) per c | Terminated |
| 2023-01-27 | Class II | Verapamil Hydrochloride Extended-Release Tablets, USP, 120 mg, Rx Only, 100 Tablets per Ca | Terminated |
| 2023-01-11 | Class II | Metoprolol Succinate | Terminated |
| 2022-12-27 | Class II | Bupropion Hydrochloride | Terminated |
| 2022-12-20 | Class II | Rifampin | Terminated |
| 2022-07-27 | Class III | Azacitidine for Injection, 100 mg Lyophilized Powder, Single-Dose Vials, Rx Only, Manufact | Terminated |